Latest News
RHYTHM AI announces publication of successful STAR Mapping™ clinical outcome trial
RHYTHM AI announces publication of successful STAR Mapping™ clinical outcome trial that identified Atrial Fibrillation (AF) drivers in all study patients STAR Mapping guided ablation of [...]
RHYTHM AI Receives MHRA Approval to Initiate the ROCSTAR Clinical Trial with STAR Mapping System
RHYTHM AI Receives MHRA Approval to Initiate the ROCSTAR Clinical Trial with STAR Mapping™ System UK Multi-Centre Trial to Recruit 177 Patients in up to 15 [...]
RHYTHM AI Announces Clinical Trial Collaboration With Biosense Webster
RHYTHM AI Announces Clinical Trial Collaboration With Biosense Webster Companies to collaborate on multi-centre study of STAR Mapping™ to improve outcomes of persistent Atrial Fibrillation treatment [...]
HRC 2019: Sequential approach using STAR mapping system identifies key early sites of activation in patients with persistent AF
HRC 2019: Sequential approach using STAR mapping system identifies key early sites of activation in patients with persistent AF The use of a Stochastic Trajectory Analysis [...]
RHYTHM AI Successfully Closes Seed Financing Round
Proceeds to fund multi-centre study of STAR Mapping™ to improve outcomes of persistent Atrial Fibrillation treatment London, UK- 10 September 2019: RHYTHM AI Ltd ("RHYTHM AI" [...]
STAR Mapping Outcome Study in AF
RHYTHM AI Ltd Announces publication of Human Clinical Outcome Study for STAR Mapping™ System for Treatment of Persistent Atrial Fibrillation 80% of patients treated for persistent [...]